|
17/01/2025
|
12:55
|
Holding(s) in Company
|
RNS
|
|
16/01/2025
|
15:42
|
Martin Murphy appointed as Non-Executive Director
|
RNS
|
|
16/01/2025
|
15:42
|
Result of General Meeting and Total Voting Rights
|
RNS
|
|
15/01/2025
|
17:37
|
£18m raised to fund Phase 2 INVENT clinical trial
|
RNS
|
|
20/12/2024
|
07:00
|
Proposed Fundraising
|
RNS
|
|
30/10/2024
|
18:09
|
Exercise of Share Options and Total Voting Rights
|
RNS
|
|
10/10/2024
|
17:05
|
Results of AGM and Appointment of New Chairman
|
RNS
|
|
26/09/2024
|
07:00
|
Interim Results
|
RNS
|
|
18/09/2024
|
07:00
|
Appointment of New Chairman and Notice of AGM
|
RNS
|
|
05/09/2024
|
07:00
|
Board Change
|
RNS
|
|
27/06/2024
|
07:00
|
2023 Full Year Results
|
RNS
|
|
15/11/2023
|
07:00
|
Grant of Options
|
RNS
|
|
11/10/2023
|
07:00
|
Appointment of New Chief Financial Officer
|
RNS
|
|
21/09/2023
|
07:00
|
Interim Results
|
RNS
|
|
29/06/2023
|
18:02
|
Result of AGM
|
RNS
|
|
29/06/2023
|
10:00
|
Annual General Meeting Presentation
|
RNS
|
|
22/06/2023
|
07:00
|
Grant of Options
|
RNS
|
|
23/05/2023
|
07:00
|
Posting of Annual Report and Notice of AGM
|
RNS
|
|
27/04/2023
|
07:00
|
2022 Full Year Results
|
RNS
|
|
17/04/2023
|
07:00
|
Notice of Full Year results
|
RNS
|
|
13/03/2023
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
|
13/03/2023
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
03/02/2023
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
|
03/02/2023
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
17/01/2023
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
13/01/2023
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
|
13/01/2023
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
14/12/2022
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
01/12/2022
|
07:00
|
Board Changes
|
RNS
|
|
07/11/2022
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
|
07/11/2022
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
03/11/2022
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
|
03/11/2022
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
20/10/2022
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
06/10/2022
|
13:35
|
Holding(s) in Company
|
RNS
|
|
04/10/2022
|
07:02
|
Data from the US NIH-led ACTIV-2 Phase 2 trial
|
RNS
|
|
29/09/2022
|
07:01
|
Board Changes
|
RNS
|
|
29/09/2022
|
07:00
|
Interim Results
|
RNS
|
|
20/09/2022
|
07:00
|
SPRINTER Long COVID data presented at IDWeek
|
RNS
|
|
15/09/2022
|
07:00
|
Notice of Interim Results
|
RNS
|
|
08/09/2022
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
|
08/09/2022
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
07/09/2022
|
07:00
|
Positive Findings from SG015 Tri-al Analysis
|
RNS
|
|
05/09/2022
|
07:00
|
Company Announce Collaboration on UNIVERSAL Trial
|
RNS
|
|
11/07/2022
|
07:45
|
SINGULUS TECHNOLOGIES AG - Violation of an Obligation under the Terms and Conditions of the Bonds - Possible Right of Termination for Bondholders
|
EQS Group
|
|
06/07/2022
|
07:00
|
Grant of Options
|
RNS
|
|
30/06/2022
|
13:45
|
Result of AGM
|
RNS
|
|
23/06/2022
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
|
23/06/2022
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
15/06/2022
|
14:30
|
Holding(s) in Company
|
RNS
|